Selected research
Industry Growth & Trends
Global Pet Drug and Vaccine Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pet Drug and Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pet Drug and Vaccine market include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Merck Animal Health, Ouro Fino Saude, Parnell and Vetoquinol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pet Drug and Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pet Drug and Vaccine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Drug and Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Drug and Vaccine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pet Drug and Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pet Drug and Vaccine Market by Company
Boehringer Ingelheim
Ceva
Dechra Veterinary Products
Elanco Animal Health
Meiji
Merck Animal Health
Ouro Fino Saude
Parnell
Vetoquinol
Virbac
Zoetis
Pet Drug and Vaccine Segment by Type
Drugs
Vaccine
Pet Drug and Vaccine Segment by Application
Dogs
Cats
Other
Pet Drug and Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Drug and Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Drug and Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Drug and Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pet Drug and Vaccine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Drugs
- Vaccine
Applications
- Dogs
- Cats
- Other
Companies covered
- Boehringer Ingelheim
- Ceva
- Dechra Veterinary Products
- Elanco Animal Health
- Meiji
- Merck Animal Health
- Ouro Fino Saude
- Parnell
- Vetoquinol
- Virbac
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pet Drug and Vaccine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pet Drug and Vaccine Market Size by Region (2021-2032)
- 1.4.1 Global Pet Drug and Vaccine Market Size by Region (2021-2026)
- 1.4.2 Global Pet Drug and Vaccine Market Size by Region (2027-2032)
- 1.5 Key Regions Pet Drug and Vaccine Market Size (2021-2032)
- 1.5.1 North America Pet Drug and Vaccine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pet Drug and Vaccine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pet Drug and Vaccine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pet Drug and Vaccine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pet Drug and Vaccine Market Size Growth Rate (2021-2032)
2 Pet Drug and Vaccine Market by Type
- 2.1 Type Introduction
- 2.1.1 Drugs
- 2.1.2 Vaccine
- 2.2 Global Pet Drug and Vaccine Market Size by Type
- 2.2.1 Global Pet Drug and Vaccine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pet Drug and Vaccine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pet Drug and Vaccine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pet Drug and Vaccine Market Size by Regions
- 2.3.1 North America Pet Drug and Vaccine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pet Drug and Vaccine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pet Drug and Vaccine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pet Drug and Vaccine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pet Drug and Vaccine Market Size Breakdown by Type (2021-2026)
3 Pet Drug and Vaccine Market by Application
- 3.1 Type Introduction
- 3.1.1 Dogs
- 3.1.2 Cats
- 3.1.3 Other
- 3.2 Global Pet Drug and Vaccine Market Size by Application
- 3.2.1 Global Pet Drug and Vaccine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pet Drug and Vaccine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pet Drug and Vaccine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pet Drug and Vaccine Market Size by Regions
- 3.3.1 North America Pet Drug and Vaccine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pet Drug and Vaccine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pet Drug and Vaccine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pet Drug and Vaccine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pet Drug and Vaccine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pet Drug and Vaccine Industry Trends
- 4.2 Pet Drug and Vaccine Industry Drivers
- 4.3 Pet Drug and Vaccine Industry Opportunities and Challenges
- 4.4 Pet Drug and Vaccine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pet Drug and Vaccine Revenue (2021-2026)
- 5.2 Global Pet Drug and Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pet Drug and Vaccine Key Company Headquarters & Area Served
- 5.4 Global Pet Drug and Vaccine Company, Product Type & Application
- 5.5 Global Pet Drug and Vaccine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pet Drug and Vaccine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pet Drug and Vaccine Players Market Share by Revenue in 2025
- 5.6.3 2025 Pet Drug and Vaccine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Boehringer Ingelheim
- 6.1.1 Boehringer Ingelheim Company Information
- 6.1.2 Boehringer Ingelheim Business Overview
- 6.1.3 Boehringer Ingelheim Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Boehringer Ingelheim Pet Drug and Vaccine Product Portfolio
- 6.1.5 Boehringer Ingelheim Recent Developments
- 6.2 Ceva
- 6.2.1 Ceva Company Information
- 6.2.2 Ceva Business Overview
- 6.2.3 Ceva Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Ceva Pet Drug and Vaccine Product Portfolio
- 6.2.5 Ceva Recent Developments
- 6.3 Dechra Veterinary Products
- 6.3.1 Dechra Veterinary Products Company Information
- 6.3.2 Dechra Veterinary Products Business Overview
- 6.3.3 Dechra Veterinary Products Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Dechra Veterinary Products Pet Drug and Vaccine Product Portfolio
- 6.3.5 Dechra Veterinary Products Recent Developments
- 6.4 Elanco Animal Health
- 6.4.1 Elanco Animal Health Company Information
- 6.4.2 Elanco Animal Health Business Overview
- 6.4.3 Elanco Animal Health Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Elanco Animal Health Pet Drug and Vaccine Product Portfolio
- 6.4.5 Elanco Animal Health Recent Developments
- 6.5 Meiji
- 6.5.1 Meiji Company Information
- 6.5.2 Meiji Business Overview
- 6.5.3 Meiji Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Meiji Pet Drug and Vaccine Product Portfolio
- 6.5.5 Meiji Recent Developments
- 6.6 Merck Animal Health
- 6.6.1 Merck Animal Health Company Information
- 6.6.2 Merck Animal Health Business Overview
- 6.6.3 Merck Animal Health Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Merck Animal Health Pet Drug and Vaccine Product Portfolio
- 6.6.5 Merck Animal Health Recent Developments
- 6.7 Ouro Fino Saude
- 6.7.1 Ouro Fino Saude Company Information
- 6.7.2 Ouro Fino Saude Business Overview
- 6.7.3 Ouro Fino Saude Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Ouro Fino Saude Pet Drug and Vaccine Product Portfolio
- 6.7.5 Ouro Fino Saude Recent Developments
- 6.8 Parnell
- 6.8.1 Parnell Company Information
- 6.8.2 Parnell Business Overview
- 6.8.3 Parnell Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Parnell Pet Drug and Vaccine Product Portfolio
- 6.8.5 Parnell Recent Developments
- 6.9 Vetoquinol
- 6.9.1 Vetoquinol Company Information
- 6.9.2 Vetoquinol Business Overview
- 6.9.3 Vetoquinol Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Vetoquinol Pet Drug and Vaccine Product Portfolio
- 6.9.5 Vetoquinol Recent Developments
- 6.10 Virbac
- 6.10.1 Virbac Company Information
- 6.10.2 Virbac Business Overview
- 6.10.3 Virbac Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Virbac Pet Drug and Vaccine Product Portfolio
- 6.10.5 Virbac Recent Developments
- 6.11 Zoetis
- 6.11.1 Zoetis Company Information
- 6.11.2 Zoetis Business Overview
- 6.11.3 Zoetis Pet Drug and Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Zoetis Pet Drug and Vaccine Product Portfolio
- 6.11.5 Zoetis Recent Developments
7 North America
- 7.1 North America Pet Drug and Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pet Drug and Vaccine Market Size by Country (2021-2026)
- 7.3 North America Pet Drug and Vaccine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pet Drug and Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pet Drug and Vaccine Market Size by Country (2021-2026)
- 8.3 Europe Pet Drug and Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pet Drug and Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pet Drug and Vaccine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pet Drug and Vaccine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pet Drug and Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pet Drug and Vaccine Market Size by Country (2021-2026)
- 10.3 South America Pet Drug and Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pet Drug and Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pet Drug and Vaccine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pet Drug and Vaccine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst